SEC Form 4 · accession 0001645627-17-000117
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 7, 2017
Accepted (ET)
Sep 12, 2017 · 2:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.0258 | A | 23,265,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.0259 | A | 23,268,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.026 | A | 23,271,189 | D | |
| Common Stock | Sep 7, 2017 | P | 5,000 | $0.0278 | A | 23,276,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.027 | A | 23,279,189 | D | |
| Common Stock | Sep 7, 2017 | P | 5,000 | $0.027 | A | 23,284,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.0269 | A | 23,287,189 | D | |
| Common Stock | Sep 7, 2017 | P | 5,000 | $0.0269 | A | 23,292,189 | D |
Table II — derivative securities
No Table II lines on this filing.